Examination of blood ghrelin and leptin concentrations during administration of calcimimetics

Examination of blood ghrelin and leptin concentrations during administration of calcimimetics - Blood ghrelin and leptin levels during administration of calcimimetics

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034615

Enrollment

Registered

2018-10-24

Start date

2018-10-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients currently visiting our hospital

Exclusion criteria

Exclusion criteria: Patients complicated with serious diseases such as cancer, hematological disorders, and liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Blood ghrelin and leptin concentration	—

Secondary

Measure	Time frame
Interview survey	—

Countries

Japan

Contacts

Public ContactMichio Kuwahara

Saitama Tsukinomori Clinic Nephrology

kuwahara@k-naika-cl.jp048-792-1811

Outcome results